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Introduction
Nonmuscle myosin II (MII) contractility is critically important 
in cell motility (Vicente-Manzanares et al., 2007). MII contains 
pairs of myosin heavy chains (MHCs), regulatory myosin light 
chains (MLCs), and essential MLCs that assemble into bipolar 
filaments with actin-stimulated ATPase activity. The resultant 
contractility drives formation of actin stress fibers and focal   
adhesions. MII also cross-links actin, which contributes to adhe-
sion assembly and stabilization of actin filaments (Choi et al., 
2008). Although MII is located away from the lamellipodium and 
nascent adhesions (Kolega, 1998, 2006; Gupton and Waterman- 
Storer, 2006), its removal or inhibition induces ectopic lamelli-
podia and adhesions (Katsumi et al., 2002; Sandquist et al., 2006; 
Even-Ram et al., 2007; Vicente-Manzanares et al., 2007). MII 
might therefore control a diffusible factor(s) that affects pro-
cesses at the leading edge.
Rac1, Cdc42, and RhoA jointly control lamellipodial and 
filopodial protrusions, adhesion dynamics, and actin stress 
fibers during migration (Nobes and Hall, 1995). Rho GTPases 
regulate MII through multiple pathways (Somlyo and Somlyo, 
2000). In general, RhoA/Rho-kinase (ROCK) activates MII 
contractility whereas Rac1 and its effector PAK often negatively 
regulate MII and decrease contractility. Efficient cell motility 
requires that Rac1/Cdc42, RhoA, and MII activity be coordi-
nated; however, the mechanisms of coordination remain in-
completely understood.
Rho  GTPases  are  activated  by  guanine  nucleotide  ex-
change factors (GEFs), most of which contain a tandem Dbl   
homology (DH)–pleckstrin homology (PH) domain as a catalytic 
core (Schmidt and Hall, 2002). Recent studies have revealed a 
connection between MII and Dbl family GEFs, suggesting their 
potential regulation by MII as well as a scaffold function (Wu   
et al., 2006; Conti and Adelstein, 2008). However, the molecular   
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poral regulation of actomyosin contraction and 
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(MII) controls Rac1 and Cdc42 activation, and cell protru-
sion and focal complex formation in migrating cells. 
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family guanine nucleotide exchange factors (GEFs). Bind-
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pleckstrin homology module, the catalytic site of these 
GEFs, with dissociation constants of 0.3 µM. Binding to 
the GEFs required assembly of the MII into filaments and 
actin-stimulated ATPase activity. Binding of MII suppressed 
GEF activity. Accordingly, inhibition of MII ATPase activity 
caused release of GEFs and activation of Rho GTPases. 
Depletion of PIX GEF in migrating NIH3T3 fibroblasts 
suppressed lamellipodial protrusions and focal complex 
formation induced by MII inhibition. The results elucidate 
a functional link between MII and Rac1/Cdc42 GTPases, 
which may regulate protrusion/adhesion dynamics in   
migrating cells.
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mechanism  is  unknown. We  therefore  investigated  how  MII 
might regulate GEFs for Rho GTPases. Our studies reveal that 
MII  regulates  multiple  Dbl  family  members  through  direct 
binding, which controls their activity and localization in migrat-
ing cells.
Results
Identification of PIX GEF as a novel  
MII-interacting protein
To test whether MII regulates Rho GTPases through Dbl family 
GEFs,  we  first  examined  whether  MII  could  associate  with 
PIX, a Rac1/Cdc42-specific GEF highly implicated in cell mo-
tility (Za et al., 2006). PC12 cells express PIX and MIIA/MIIB 
at high levels, so they were used for most immunoprecipitation 
(IP) experiments on this GEF. PIX IPs in PC12 cells contained 
MIIA and MIIB, whereas nonimmune IPs showed no associa-
tion (Fig. 1 A). To test the specificity of the interaction, we 
screened Jurkat T cells and C2C12 myoblasts that expressed 
MIB and MVa, respectively (Fig. 1 A). No interaction between 
PIX and myosin IB, Va, or VI was detected, indicating that the 
MII–PIX interaction is specific (Fig. 1 A).
To identify the domain(s) involved in the PIX–MII inter-
action, multiple MIIB and PIX constructs were examined   
(Fig. 1, B and C, top). MIIB constructs were tagged with GFP 
and expressed in PC12 cells. IP with anti-GFP antibody followed 
by immunoblotting for endogenous PIX showed that the MII 
head domain bound PIX (Fig. 1 B, bottom). Conversely, analy-
sis of PIX constructs showed that only the N terminus of PIX 
associated with MIIB (Fig. 1 C, bottom left). Further analysis   
revealed the DH domain as the MIIB interaction site (Fig. 1 C, 
bottom right). To confirm these results, the PIX DH domain 
was overexpressed as GST-tagged proteins. Addition of this do-
main to cell lysates blocked coIP of MIIB and PIX, whereas 
GST alone or PIX SH3 domain had no effects (Fig. 1 D).
MII directly interacts and colocalizes with 
the Dbl family of GEFs
The high conservation of the DH domain led us to test whether 
other Dbl family GEFs also bind MII. We therefore expressed 
myc-tagged GEFs and tested for association with endogenous 
MIIB (Fig. 2 A). MIIB was present in IPs of all of the Dbl family 
of GEFs tested, but not with ARNO or smgGDS, which are GEFs 
that lack DH domains. Next, we examined the interaction be-
tween endogenous MII and GEFs. In rat brain lysate, the GEFs 
kalirin, FGD1, and LARG were readily detected (Fig. 2 B, top 
left), whereas PC12 cells expressed PIX and Tiam1 (Fig. 2 B, 
top center) and NIH3T3 cells expressed GEF-H1, Dbl, and Trio 
(Fig. 2 B, top right). IP of MIIB revealed association with all of 
these GEFs to varying extents. When quantified by densitometry, 
the percentage of GEFs present in MII IPs varied from nearly 9   
to  1%  (Trio,  8.7%;  GEF-H1,  8.2%;  FGD1,  8.1%;  Kalirin, 
5.6%; PIX, 3.0%; LARG, 1%; Dbl, 1.3%; Tiam1, 1.6%). We 
also compared MIIA to MIIB. The amounts of PIX and Trio in 
MIIA IPs were 3.5% and 10.7%, respectively (Fig. 2 B, bottom). 
However, GEF-H1 decreased to 2.6% compared with 8.2% for 
MIIB IPs. Thus, some quantitative differences were observed.
Figure 1.  Identification and characterization of interaction between MII 
and PIX. (A) Specific interaction of MII with PIX. Cell lysates were immuno-
precipitated with anti-PIX antibody followed by immunoblotting for the   
indicated myosins (top). Blots were reprobed for PIX (bottom). (B) The MIIB 
head domain as the binding site. Schematic diagram of the MIIB constructs 
(top). Cells were transfected with plasmids for the indicated MIIB constructs 
(bottom). Lysates were immunoprecipitated with anti-GFP antibody and   
immunoblotted for GFP or PIX. (C) DH domain of PIX as the binding site. 
Schematic diagram of the domain structure of PIX (top). Full-length PIX 
(FL-PIX), N-terminal PIX (N-PIX), or C-terminal PIX (C-PIX) were expressed 
as myc-tagged proteins. The SH3, DH, or PH domains were expressed as   
GFP fusion proteins. Cells were transfected with plasmids for the indicated 
PIX constructs (bottom). Lysates were immunoprecipitated with anti-myc 
(left) or anti-GFP (right) antibodies and immunoblotted for MIIB or myc/GFP-
tagged proteins. (D) Blocking the interaction between endogenous MIIB 
and PIX with recombinant proteins. The DH domain of PIX (DH) and 
the PIX SH3 domains were expressed in Escherichia coli as GST-tagged 
proteins and purified. Cell lysates were immunoprecipitated for MIIB (top) 
in the presence of the 5 µg recombinant proteins. Interactions were moni-
tored by immunoblotting for PIX. Loading of PIX from the lysates and the 
recombinant proteins were verified (bottom). Blots are representative of 
three independent experiments.665 Regulation of Dbl family GEFs by myosin II • Lee et al.
60–62% similar, which rises to 68% at their head domains. Both 
skeletal and cardiac muscle MII bound to the DH–PH domains 
(Fig. 2 D). Thus, interactions with GEFs are direct and extend 
to all MII isoforms.
We next measured binding affinity using a Biacore system. 
Varying concentrations of MII were applied to GST (control) or 
GST–DH–PH immobilized on chips. Specific binding between 
the PIX DH–PH domain and MII was observed after subtrac-
tion of nonspecific GST binding. The calculated KD was 0.26 µM 
(Fig. 2 E). The DH–PH domains from Tiam1 and Vav1 showed 
similar KD values of 0.29 and 0.39 µM, respectively (not de-
picted). Given the micromolar concentrations of MII in cells, 
these KD values suggest that a substantial fraction of GEFs could 
be bound to myosin in cells.
As the PIX DH domain alone showed substantial bind-
ing to MIIB (Fig. 1 C), the potential involvement of other DH 
domains was assessed. Myc-tagged PIX DH domain consis-
tently bound MIIB (Fig. 2 C, left). DH domains from Tiam1 
and Vav1 also coimmunoprecipitated with MIIB, whereas those 
from GEFT and collybistin did not. However, DH–PH modules 
from GEFT and collybistin efficiently associated with MIIB 
(Fig. 2 C, right), whereas GFP alone did not. Thus, the DH–PH 
module or, in some cases, the DH domain alone, mediates 
MIIB binding.
To determine whether binding was direct, in vitro binding 
analyses used purified MIIs from skeletal and cardiac muscle, 
together  with  recombinant  GST-tagged  PIX  and  Tiam1   
DH–PH domains. Human muscle and nonmuscle MII are overall 
Figure 2.  Direct interaction and colocalization 
of MII with GEFs. (A) Specific interaction of en-
dogenous MIIB with ectopically expressed Dbl 
family GEFs. PC12 cells were transfected with 
myc-tagged  GEFs  (right),  or  with  ARNO  or 
smgGDS GEF, which lacks a DH domain (left). 
Cell  lysates  were  immunoprecipitated  with 
anti-myc antibody followed by immunoblotting 
for MIIB (top). Expression of transfected genes 
was verified with anti-myc antibody (bottom). 
(B) Quantification of interactions between en-
dogenous MIIA/MIIB and GEFs. Lysates (1 mg)   
from rat brain (E18), PC12, or NIH3T3 cells   
were  immunoprecipitated  with  anti-MIIA  or   
MIIB antibody followed by immunoblotting for   
the indicated GEFs. All of the immunoprecipi-
tated proteins were loaded in each IP lane.   
A fraction (30 µg) of the same lysates for IP 
was loaded in each WCL lane. The percentage   
of each MII-bound GEF was calculated from   
dividing the relative densitometric values from   
the IP lane by those from the paired WCL lane. 
(C) Involvement of the DH–PH domain in inter-
actions with MIIB. (Top) Myc-tagged GFP (con-
trol) or the DH domains from the various GEFs 
were expressed in PC12 cells. Lysates were im-
munoprecipitated with anti-myc antibody and 
immunoblotted for MIIB. (Bottom) Myc-tagged 
DH–PH  domains  from  GEFT,  collybistin,  or 
Vav1  (positive  control)  were  expressed  and   
lysates were processed as described above.   
(D) Direct interaction of MII with DH–PH do-
mains. Purified recombinant GST–DH–PH do-
mains (2 µg) were incubated with MII (1 µg) from 
skeletal  or  cardiac  muscle,  then  precipitated 
with glutathione agarose beads. Bound mate-
rial was analyzed by immunoblotting for skele-
tal or cardiac MII. (E) Binding sensorgrams for 
the DH–PH domain and MII. His-tagged C-PIX 
(control, see Fig. 1 C) or DH–PH domain were 
immobilized on a Ni
2+-NTA sensor chip and 
MII was passed over the immobilized proteins. 
Surface plasmon resonance was recorded and   
nonspecific binding of MII with C-PIX was sub-
tracted  from  each  DH–PH  binding  curve.   
(F) Colocalization of MIIs and GEFs. Swiss 3T3 
cells  were  serum  starved  overnight  and  co-
stained for PIX (green) and MIIA/MIIB (red) 
(top), and for Trio (green) and MIIA/MIIB (red) 
(bottom). Enlarged images are shown on the 
right. Data are representative of three indepen-
dent experiments. Bar, 10 µm.JCB • VOLUME 190 • NUMBER 4 • 2010   666
Figure 3.  MII ATPase activity critically regulates MII–GEF association. (A) BBS-induced dissociation of the MII–DH–PH complex in vitro. Skeletal muscle MII 
(1 µg) was incubated with His-tagged DH–PH domains (5 µg) from PIX, Vav1, Tiam1, or Dbs, with or without 50 µM BBS at 25°C for 30 min, followed 
by precipitation with Ni
2+ beads. Bound MII was detected by immunoblotting and analyzed by densitometry. Numbers indicate binding relative to BBS-
untreated lanes. (B) BBS-induced dissociation of the MII–GEF complex in cells. Various myc-tagged GEFs were expressed in 293T cells and treated with 
DMSO (control) or 20 µM BBS for 1 h. Lysates (1 mg) were immunoprecipitated with anti-myc antibody and immunoblotted for MIIB (top) or myc (bottom). 
Bands were quantified by densitometry. The results are expressed as band intensity relative to untreated samples and shown below the band of each GEF. 
(C) Dose-dependence for BBS. PC12 cells were incubated with the indicated concentrations of BBS for 1 h. Lysates were then immunoprecipitated with 667 Regulation of Dbl family GEFs by myosin II • Lee et al.
which is controlled in cells by ROCK and MLCK (Gallagher   
et al., 1991). Both the specific MLCK inhibitor ML-7 and the 
ROCK inhibitor Y-27632 decrease MII ATPase activity. We 
found that these inhibitors disrupted the MII–PIX complex in   
a dose-dependent manner (Fig. S3, A and B). Inhibition of 
the RhoA/ROCK pathway with dominant-negative N19RhoA 
also significantly reduced coIP of MIIB-PIX, whereas GFP or 
GFP-active V14RhoA had no effect (Fig. 4 A). Cellular ATP de-
pletion can also inactivate MII, most likely through the down-
regulation of RhoA/ROCK activity (Raman and Atkinson, 1999). 
Depleting ATP with antimycin A, an inhibitor of the complex III 
in the mitochondrial respiratory chain (Canfield et al., 1991),   
resulted in time- and dose-dependent inhibition of MIIB–PIX 
coIP (Fig. 4 B). ATP depletion also inhibited MII binding to 
GEFT, Vav1, Tiam1, and GEF-H1 (Fig. S3 C). These data show 
that reducing MLC phosphorylation decreased the interaction 
with GEFs.
MII  ATPase  activity  is  stimulated  by  F-actin  and   
requires MII assembly into thick filaments. Prominent asso-
ciation of PIX/Trio with MII along the actin stress fibers 
suggests that assembled, active MII filaments mediate the as-
sociation with GEFs (Fig. 2 F and Fig. S1). To test this idea, 
we addressed whether F-actin affects the formation of MII–
GEF complex in vitro. Based on the finding that DH–PH do-
main bound to MII (Fig. 2, D and E), recombinant DH–PH 
domains from PIX, Tiam1, or Vav1 were incubated with 
skeletal muscle MII in the absence or presence of F-actin. Be-
cause the C-terminal half of PIX (C-PIX) does not bind MII 
(Fig. 1 C), it was used as a negative control. C-PIX showed   
a low level of binding, which was not affected by F-actin   
(Fig. 4 C, left). In contrast, F-actin stimulated the association 
of the DH–PH domains with MII by two- to fourfold. To test 
the importance of F-actin for this interaction in cells, they 
were  treated  with  cytochalasin  D,  which  reduces  levels  of   
F-actin. Compared with vehicle (DMSO), cytochalasin D de-
creased coIP of MIIB with PIX, though less efficiently than 
BBS (Fig. 4 C, right).
Next,  we  compared  full-length  MII  to  soluble  HMM, 
which cannot polymerize due to deletion of the C terminus. 
Soluble HMM bound to PIX DH–PH domain in vitro less 
well than full-length MII (Fig. 4 D). To address this issue in 
cells, assembled MII was separated from soluble MII by mild 
detergent extraction (0.5% Triton X-100 in low salt with Mg
2+, 
first fraction); the pellets were then solubilized using harsher 
buffer (1% Triton X-100 in high salt without Mg
2+, second 
fraction) to retrieve assembled MII. Approximately 90% of the 
MIIA and 60% of the MIIB were in the first fraction (Fig. 4 E, 
left), similar to previous results from A549 cells (Sandquist 
and Means, 2008). We therefore concentrated on MIIB, which 
was more evenly distributed. Both pools were then subject to 
Next, subcellular colocalization of MII and GEFs was exam-
ined. PC12 cells do not spread well and have less well-defined cyto-
skeletal compartments; thus, we used two 3T3 cell lines for this 
study. In Swiss 3T3 fibroblasts, MII stains actin stress fibers, as ex-
pected. PIX colocalized with both MIIA and MIIB along the stress 
fibers, in addition to staining of elongated puncta at the end of stress 
fibers, consistent with its known focal adhesion localization 
(Manser et al., 1998), and some diffuse cytosolic staining (Fig. 2 F, 
top). Exogenously introduced myc-PIX showed a similar linear   
localization along the stress fibers (Fig. S1). The neuronal GEF Trio 
has not previously been investigated in nonneuronal cells, but in 
fibroblasts we observed striking appearance along the stress fibers 
(Fig. 2 F, bottom). Merged images showed substantial colocalization 
for both PIX/MII and Trio/MII, which was stronger for Trio/MII, 
in correlation with more efficient coIP (Fig. 2 B). Similar colocal-
ization of these GEFs was observed in NIH3T3 fibroblasts, though 
stress fibers were less prominent than in Swiss 3T3s (Fig. S2).
MII ATPase activity is required for 
association of MII with GEFs
MII is an actin-based molecular motor that requires ATPase   
activity to generate contractile force. To investigate the role for 
ATPase activity in the GEF interaction, we used blebbistatin 
(BBS), which specifically inhibits ATPase activity (Straight   
et al., 2003; Kovács et al., 2004). BBS significantly attenuated 
the association of DH–PH domains from PIX, Vav1, Tiam1, 
and Dbs with skeletal muscle MII (Fig. 3 A). Similar results 
were obtained using full-length GEFs expressed in 293T cells, 
which transfect efficiently (Fig. 3 B). Densitometry revealed 
that inhibition ranged from 94% for intersectin to the 63% for 
kalirin-7. Binding of endogenous PIX to MIIA and IIB was 
inhibited by BBS in a dose-dependent manner, revealed by IP of 
both PIX (Fig. 3 C, left) and MIIB (Fig. 3 C, right).
To confirm these results, we analyzed ATPase-defective 
MII heavy chain mutants: MIIA N93K, MIIB N97K, and MIIB 
R709C. These mutants displayed 4%, 70%, and 29%, respec-
tively, of the maximal actin-activated ATPase activity of the 
wild type in vitro (Hu et al., 2002; Kim et al., 2005). To enhance 
expression levels, these mutants were expressed in 293T cells as 
heavy meromyosin (HMM), composed of a globular head do-
main, neck region, and a small fragment of the tail. The MIIA 
N93K, MIIB N97K, and MIIB R709C mutants bound much 
less PIX compared with WT MII (Fig. 3 D, top). Reciprocal IP 
of PIX gave similar results (Fig. 3 D, bottom). Thus, MII 
ATPase activity is required for its association with GEFs.
MLC phosphorylation and actomyosin 
assembly facilitates GEF binding to MII
MII assembly into thick filaments and ATPase activity are regu-
lated  by  MLC  phosphorylation  (Adelstein  and  Conti,  1975), 
an anti-PIX (left) or anti-MIIB (right) antibody. Interactions were detected by immunoblotting for MIIA, MIIB, or PIX. Bound MII or PIX was analyzed by 
densitometry and the results are expressed relative to BBS-untreated control. (D) Analysis of PIX binding by ATPase activity–deficient MIIs. (Left) GFP-tagged 
wild type or mutant (N93K) of MIIA HMM was expressed in 293T cells. Lysates were immunoprecipitated with anti-GFP (top) or anti-PIX (bottom) followed 
by immunoblotting for PIX, GFP for HMM constructs, or MIIA. (Right) GFP-tagged wild type or mutant (N97K/R709C) of MIIB HMM was expressed in 
293T cells. Lysates were immunoprecipitated with anti-GFP (top) or anti-PIX (bottom) followed by detection for PIX, GFP for HMM constructs, or MIIB. 
Blots are representative of three independent experiments.
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with MIIB (Fig. 4 E, top center). In the reciprocal coIP experi-
ment, PIX associated mainly with MIIA and MIIB in the sec-
ond assembled pool (Fig. 4 E, bottom center). Longer exposure 
revealed a weak association in the first soluble pool. These re-
sults support the idea that GEFs bind preferentially to assem-
bled F-actin and MII filaments.
IP with anti-MIIB antibody and Western blotting. When nor-
malized to the amount of MIIB in the IPs, the amount of PIX 
and Trio was four- to sevenfold higher for assembled MIIB 
compared with the soluble pool (Fig. 4 E, center and right). 
GAPDH was present in both fractions (Fig. 4 E, left), and thus 
was used as a negative control. It did not coimmunoprecipitate 
Figure 4.  Stimulation of MII–GEF association by MLC phosphorylation and actomyosin assembly. (A) Inhibition of RhoA dissociates the MIIB–PIX complex. 
293T cells were transfected with the GFP control plasmid, dominant-active V14RhoA, or dominant-negative N19RhoA. The next day, lysates were immuno-
precipitated with anti-MIIB antibody followed by immunoblotting for PIX (top) or MIIB (bottom) (top). Expression of transfected genes was monitored by 
immunoblotting for GFP (bottom). (B) ATP depletion dissociates the MIIB–PIX complex. (Top) NIH3T3 cells were incubated with depletion medium contain-
ing the indicated concentrations of antimycin A for 30 min. Lysates were immunoprecipitated with anti-PIX and subjected to immunoblotting. (Bottom) Cells 
were treated with antimycin A (100 nM) for the indicated times. Lysates were processed as described above. Bound MIIB was analyzed by densitometry 
and the results are expressed relative to antimycin A–untreated controls. (C) F-actin stimulates association of the MIIB–DH–PH complex in vitro. (Left) 2 g 
full-length skeletal muscle MII was incubated with 5 µg His-tagged C-PIX (negative control) or 5 µg DH–PH domains from PIX, Tiam1, or Vav1 in the ab-
sence or presence of 0.2 mg/ml F-actin. MII–DH–PH complex was pulled down using Ni
2+ beads. Bound MII was monitored by immunoblotting for muscle 
MII. (Right) Cells were incubated with DMSO, BBS (50 µM), or cytochalasin D (CCD, 10 µM) for 30 min. Lysates were immunoprecipitated with anti-PIX 
and immunoblotted for MIIA or MIIB. (D) Thick filament assembly-dependent association of MII and DH–PH domain in vitro. HMM and full-length MII were 
incubated with the DH–PH domains from PIX in the presence of F-actin. The complex was pulled down using Ni
2+ beads, and bound HMM and MII were 
detected by immunoblotting for MII. Blots are representative of three independent experiments. (E) Assembly-dependent association of MII and GEFs in 
cells. (Left) NIH3T3 cells were extracted with mild, cytoskeleton stabilizing buffer conditions (first extract) and pellets then extracted with harsher buffer that 
solubilizes assembled myosin (second extract; Sandquist and Means, 2008). Distribution of MIIA, MIIB, PIX, GAPDH, and -actin in these fractions was 
monitored by immunoblotting. (Center) Both fractions were immunoprecipitated with anti-MIIB or anti-PIX antibody followed by immunoblotting for PIX, 
Trio, GAPDH, MIIA, or MIIB. (Right) Densitometry was performed on blots from three independent experiments. MIIB-bound GEFs were normalized to the 
immunoprecipitated amount of MIIB. The normalized value of each GEF for the first fraction was arbitrarily set to 1 and the relative ratio for the second 
faction was indicated. Bar graphs represent the mean ± SEM.669 Regulation of Dbl family GEFs by myosin II • Lee et al.
2007; Vicente-Manzanares  et  al.,  2007). We  therefore  tested 
whether BBS-induced release of GEFs from MII mediated these 
events in cells. PIX is a prominent GEF in fibroblasts (Cau and 
Hall, 2005); thus, we assessed this GEF in NIH3T3 cells. CoIP 
showed almost complete dissociation of PIX from MIIA/IIB 
30 min after BBS treatment (Fig. S4 A). Staining of cells after 
BBS treatment showed an irregular and diffuse staining of MIIA/
IIB, and loss of stress fibers and increased lamellipodia (Fig. S4 B). 
PIX became localized to a linear array of small puncta along 
the lamellipodia, previously described as focal complexes 
(Manser et al., 1998). To examine whether release of PIX me-
diates the change in cell morphology, this protein was depleted 
using siRNA. PIX knockdown reached 70–80%, as monitored 
by Western blotting (Fig. 6 A, bottom left) and fluorescence in-
tensity (Fig. 6 A, top right). In scrambled siRNA-treated cells 
without BBS, vinculin localized to large focal adhesions at the 
cell periphery that overlapped with PIX (Fig. 6 A, top left). 
BBS treatment caused a dramatic shift from large adhesions to 
numerous small focal complexes at the cell margin. PIX siRNA 
had little effect on its own (Fig. 6 A, top right), but diminished 
the effect of BBS treatment by 50% (Fig. 6 A, bottom right). 
The increase in lamellipodia was also blocked (Fig. 6 B, top 
left); in fact, PIX knockdown converted the BBS-induced in-
crease to a decrease (Fig. 6 B, bottom). Collectively, these data 
suggest that BBS-induced release of PIX leads to activation of 
Rac1, which induces lamellipodia and focal complexes.
PDGF induces transient dissociation of MII 
and PIX by inactivating MII
BBS or antimycin A treatment inactivates MII, which results in 
release of GEFs and activation of Rac1/Cdc42. If this process is 
physiologically relevant, it should occur in response to physio-
logical  stimuli.  PDGF  potently  stimulates  fibroblast  motility, 
which involves disassembly of focal adhesions and actin stress   
fibers and activation of Rac1 (Herman and Pledger, 1985; 
Greenwood et al., 2000; Jiménez et al., 2000). To test whether 
PDGF causes dissociation of the MII–GEF complex before Rac1 
Dbl family GEFs are catalytically inactive 
when complexed with MII
As the catalytic DH–(PH) domain was shown to be MII binding 
site, we investigated the effects of MII binding on GEF activity. 
His-tagged DH–PH constructs were incubated with skeletal MII 
in vitro in the presence of GTPases and GTP. GEF activities 
were then measured using the p21-binding domain (PBD) pull-
down assay (Benard et al., 1999). The Vav1 DH–PH domain 
alone showed high GEF activity toward Rac1 (Fig. 5 A, top, 
lanes 1–4), which was strongly inhibited by incubation with MII 
(compare lanes 4 and 6). DH–PH domains from Tiam1 and Dbs 
were similarly affected (not depicted). We further asked whether 
the suppressed GEF activity by bound MII could be reactivated 
by treatment with BBS that dissociates GEFs from MII (Fig. 3, 
A and B). Blebbistatin treatment indeed reactivated the GEF   
activity (compare lanes 6 and 7). To test whether the full-length 
GEFs in cells were inhibited by binding MII, cells were treated 
with BBS, cytochalasin D, or antimycin A to release GEFs from 
MII. The lysates were then subjected to a pull-down assay for 
measurement of Rac1, Cdc42, and RhoA activities. All these 
treatments caused activation of both Rac1 and Cdc42 (Fig. 5 B, 
top). In accordance with our results, these GTPases are also acti-
vated by treatment with ML-7 or Y-27632 (Katsumi et al., 2002; 
Grewal et al., 2008), which also reduced MII binding to GEFs 
(Fig. S2, A and B). No significant changes in RhoA activity 
were detected (Fig. 5 B, bottom), though nocodazole treatment 
induced a marked RhoA activation, as previously reported (Ren 
et al., 1999; Krendel et al., 2002; Chang et al., 2008). Together, 
these results support the idea that binding of MII inhibits GEF 
activity toward Rac1 and Cdc42.
BBS-induced release and activation of 
GEFs may be responsible for alteration in 
cell protrusion and adhesion
BBS and other inhibitors of MII induce membrane ruffling and 
activation of Rac and Cdc42 in multiple cell types (Katsumi   
et al., 2002; Loudon et al., 2006; Ryu et al., 2006; Even-Ram et al., 
Figure 5.  Suppression of GEF activity by MII. (A) Suppression of GEF activity by MII in vitro. GEF activity of recombinant His-tagged DH–PH domain of 
Vav1 expressed in E. coli toward Rac1 was measured in the absence (lanes 1–4) or presence (lanes 5 and 6) of MII or with BBS (50 µM) for 30 min (lane 7). 
(B) Suppression of GEF activity by MII in cells. (Top) NIH3T3 cells were treated with BBS (50 µM), antimycin A (100 nM), or cytochalasin D (10 µM) for   
30 min. Rac1/Cdc42 activation was assessed using GST-PBD pull-down assays as described in Materials and methods. (Bottom) RhoA activation was   
assessed using the GST-RBD pull-down assay. NCD, nocodazole. Blots are representative from three independent experiments.JCB • VOLUME 190 • NUMBER 4 • 2010   670
activation, NIH3T3 cells were stimulated with PDGF, then lysed 
and PIX immunoprecipitated. Western blotting for MIIA and 
MIIB  showed  that  PDGF  treatment  disrupted  the  complexes   
between MII isoforms and PIX at 10–20 min after PDGF   
stimulation, followed by reformation at 30 min (Fig. 7 A, left).
Dissociation of the MIIB–PIX complex was dose dependent with 
maximum effects at 50 ng/ml of PDGF (Fig. 7 A, right). Subse-
quent experiments used this PDGF concentration for stimulation.
We next addressed whether MII inactivation was responsi-
ble for the transient release of GEFs from MII. Comparison   
of the time courses for PDGF-induced changes in actin cytoskel-
eton and focal adhesions (Herman and Pledger, 1985; Greenwood 
et al., 2000) to dissociation of the MII–GEF complexes (Fig. 7 A) 
was consistent with a causal role for MII inactivation in MII–GEF 
dissociation. As a functional test of this idea, the MLC mutants, 
MLC
AA and MLC
EE, in which Ser1/Ser2 and Thr18/Ser19 were 
replaced by alanines and glutamic acids, respectively, were pre-
pared. These mutants have been demonstrated to incorporate into 
MII as well as wild-type MLC (MLC
WT) and confer resistance to 
PDGF-induced disassembly of stress fibers (Amano et al., 1998; 
Totsukawa et al., 2004; Komatsu and Ikebe, 2007). Lysates from 
cells expressing wild-type or mutant MLC were immunoprecipi-
tated with anti-PIX antibody and subjected to immunoblotting 
with anti-MIIB antibody. PDGF treatment dissociated MII and 
PIX in vector or wild-type MLC-transfected cells, but MLC
AA 
or MLC
EE expression blocked this effect (Fig. 7 B). This effect 
was  further  analyzed  by  immunofluorescence.  Before  PDGF 
treatment, MLC and PIX stained mainly stress fibers and some 
cortical actin structures (Fig. 7 C, left). Their colocalization was 
most apparent along the stress fibers. PDGF treatment triggered 
loss  of  stress  fibers  and  more  diffuse  PIX  staining.  Mutant   
MLC
AA or MLC
EE in untreated cells resembled wild-type MLC 
(Fig. 7 C, center and right); however, cells expressing these mu-
tants were largely resistant to PDGF stimulation. Importantly, 
PIX in these cells remained colocalized on stress fibers. Trio 
gave very similar results (Fig. S5). The collective results support 
the model that PDGF-induced MII inactivation leads to the disso-
ciation of MII–GEF complex.
Because Rac1 and Cdc42 were strongly activated by the 
stimuli that released GEFs from MII (Fig. 5 B), we sought to de-
termine whether PDGF-induced release of GEFs also stimulated 
these GTPases. A transient wave of Rac1 activation was observed 
within 2 min after PDGF treatment (Fig. 7 D, top), followed by a 
second  wave  of  Rac1  activation  at  30–40  min  that  gradually   
decreased. No noticeable Cdc42 activation was observed (unpub-
lished data). Because the second wave of Rac1 activation corre-
sponded to the release of GEFs from myosin, we tested whether 
blocking GEF release with active MLC
EE eliminated the sec-
ond wave. Cells expressing MLC
WT showed two waves of Rac1  Figure 6.  Requirement for PIX in MII-regulated cell protrusion and adhe-
sion. (A) PIX mediates BBS-induced focal complex formation. Cells were 
treated with scrambled siRNA (Scr) or PIX-specific siRNA for 2 d and then 
treated with DMSO or BBS for 30 min. (Top) Cells were fixed and stained 
for PIX (green) and vinculin (red). Merged images are shown at the bot-
tom. Bar, 10 µm. (Bottom) Knockdowns were monitored by immunoblotting 
(left). To quantify focal complex formation, we calculated the relative ratio, 
as defined in Materials and methods (right). The value of the relative ratio 
in control siRNA-treated cells (n = 29) was set to 1 and compared with that 
from PIX siRNA-treated cells (n = 26). Quantitative data are expressed 
as means ± SEM. Note transformation of focal adhesions (arrows) to focal 
complexes (arrowheads) by BBS. (B) PIX mediates BBS-induced lamellipodial 
 
protrusion. (Top) Cells were treated as described in A and stained for PIX 
(green) and actin (red). (Bottom) To quantify lamellipodia formation, the 
relative ratio as defined in Materials and methods was obtained from each 
group of four. The values of the relative ratio in the two DMSO-treated 
groups (n = 48 for Scr siRNA; n = 36 for PIX siRNA) were arbitrarily 
set to 1 and compared with those from the paired BBS-treated groups   
(n = 31 for Scr siRNA; n = 27 for PIX siRNA). Values are means ± SEM. 
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Discussion
Cell migration is an integrated process in which protrusion, ad-
hesion  and  contraction  are  coordinated  (Lauffenburger  and 
Horwitz, 1996; Mitchison and Cramer, 1996). It is well estab-
lished that Rho GTPases control MII contractility by modulat-
ing MLC/MHC phosphorylation. Conversely, MII controls Rho 
GTPases,  as  inhibition  of  MII  by  multiple  means  activates 
activation in response to PDGF stimulation, even though the sec-
ond wave appeared earlier than in untransfected cells (Fig. 7 D, 
bottom left). In contrast, expression of MLC
EE completely sup-
pressed only the second peak, while having no effect on the first 
peak of Rac activity (Fig. 7 D, bottom right). These results sup-
port the notion that MII inactivation–induced release of GEFs 
and their subsequent activation mediates Rho GTPase activation 
after PDGF treatment.
Figure 7.  PDGF-induced dissociation of the MII–PIX complex. 
(A)  PDGF  transiently  dissociates  the  MII–PIX  complex.  (Top) 
NIH3T3 cells were serum starved overnight and treated with   
50 ng/ml PDGF for the indicated times. Lysates were immunopre-
cipitated with anti-PIX antibody followed by immunoblotting for 
MIIA or MIIB. (Bottom) Cells were treated for 20 min with the indi-
cated concentrations of PDGF. Lysates were immunoprecipitated 
with  anti-PIX  antibody  followed  by  immunoblotting  for  MIIB.   
(B) MLC mutants block PDGF-induced dissociation of the MIIB–PIX 
complex. Cells were transfected with myc-tagged wild-type MLC 
(MLC
WT), MLC
AA (S1A/S2A), or MLC
EE (T18E/S19E). After 2 d, 
cells were treated with 50 ng/ml PDGF for 20 min. Lysates were 
immunoprecipitated with anti-PIX antibody and immunoblotted 
for MIIB or PIX. (C) Co-staining for PIX and MLC mutants. Cells 
were transfected with myc-tagged MLC
WT (left), MLC
AA (center), 
or MLC
EE (right). After 1 d, cells were replated onto fibronectin-
coated coverslips for 16 h, then treated with PDGF for 20 min. 
They were then fixed and stained for MLC (green), PIX (red), and 
F-actin with Alexa Fluor 350–conjugated phalloidin. Bar, 10 µm. 
(D) PDGF stimulates biphasic Rac1 activation. Cells were treated 
with 50 ng/ml PDGF for the indicated times. Rac1 activation was 
assessed  using  a  GST-PBD  pull-down  assay  in  nontransfected 
(top) and MLC-transfected cells (bottom). Data are representative 
of three independent experiments.JCB • VOLUME 190 • NUMBER 4 • 2010   672
and spatial aspects of these processes regulate cell motility will 
be an important direction for future research.
Cell motility is driven by an alternating process of actin   
polymerization–dependent  protrusion  and  MII-dependent  con-
traction. The molecular mechanism for coordination of these two 
processes is incompletely understood. We propose a novel role 
for MII as a regulator of Dbl family GEFs in coordinating these 
processes. Assembled, contractile MII associates with Dbl family 
GEFs and inhibits their catalytic activity, thereby suppressing ac-
tivation of Rac1 and Cdc42, and subsequent cytoskeletal remod-
eling including formation of protrusions. It is noteworthy that 
myosin-containing actin stress fibers are most prominent along 
quiescent regions of the cell edge toward the back and sides, and 
absent from protrusive regions (Kolega, 1998, 2006; Gupton and 
Waterman-Storer, 2006). Stimuli that cause myosin inactivation 
lead to release of GEFs and activation of Rac1/Cdc42 GTPases. 
We therefore speculate that cycling of myosin between assembled/
contracted and disassembled/relaxed states may represent a spatio-
temporal regulatory mechanism in cell migration.
In conclusion, we provide a potential molecular mecha-
nism for GEF regulation by MII in cell protrusion and adhesion. 
As MII and GEFs are ubiquitously expressed, it is also conceiv-
able that cross talk between MII and a specific GEF(s) may rep-
resent a general mechanism to regulate diverse actomyosin-based 
cellular activities such as cell adhesion and cytokinesis.
Materials and methods
Antibodies and reagents
Anti-myosin, Tiam1, Dbl, LARG, FGD1, and Trio antibodies were purchased 
from Santa Cruz Biotechnology, Inc. Anti-GEF-H1 and Vav1 antibodies 
were obtained from Cell Signaling Technology. Anti-kalirin antibody was 
purchased from Millipore. Anti-skeletal and cardiac muscle myosin antibodies 
were purchased from Abcam. Rabbit skeletal or cardiac muscle MII, HMM, 
and preformed F-actin were purchased from Cytoskeleton, Inc. Secondary 
Alexa Fluor 488–, 546–, 594–conjugated antibodies, Alexa Fluor 350–
conjugated  phalloidin,  and  PIX  siRNA  (5-TTGTCTATCAGGATGATA-
ATCCTCC-3) were purchased from Invitrogen. TRITC-conjugated phalloi-
din, PDGF, cytochalasin D, nocodazole, antimycin A, ML-7, and Y-27632 
were obtained from Sigma-Aldrich. BBS was purchased from Tocris Bio-
science. Sensor chip NTA and buffers for surface plasmon resonance binding 
assay were obtained from GE Healthcare.
Plasmid constructs
Full-length cDNAs were purchased from the following sources: human non-
muscle MIIB heavy chain (NMYH-IIB: MGC134913) from Addgene; colly-
bistin, GEFT, intersectin, and myosin light chain (MLC) from American Type 
Culture Collection (Manassas, VA); PDZRhoGEF and smgGDS from Kazusa 
DNA Research Institute; and GEF-H1, FGD1, and ARNO from 21C Frontier 
Human Gene Bank (Daejeon, Korea). cDNAs for the PIX DH/DH–PH do-
main (amino acid [aa] 100–276/100–400); the Tiam1 DH/DH–PH domain 
(aa 1048–1239/1048–1406); GEFT (aa 163–334/163–466); collybistin 
(aa 108–285/104–426); and Vav1 (aa 195–352/195–508) were sub-
cloned into pCMV-myc (Takara Bio Inc.) or the pET-24a vector (EMD). The 
cDNA for N-PIX (aa 1–400), C-PIX (aa 401–647), and MLC were each sub-
cloned into pCMV-myc (Takara Bio Inc.). The cDNA for Head (aa 1–843); 
Rod-1 (aa 844–1319); Rod-2 (aa 1320–1976); or HMM (aa 1–1045)   
for nonmuscle MIIB and HMM (aa 1 –1040) for nonmuscle MIIA were   
each  subcloned  into  the  pEGFP  vector.  Mutant  constructs  of  HMM  and   
MLC  were  generated  using  a  QuikChange  site-directed  mutagenesis  kit   
(Agilent Technologies) according to the manufacturer’s protocol. The follow-
ing  primers  were  used  for  mutagenic  polymerase  chain  reaction  (PCR):   
HMM  (MIIA):  sense  5-CTCACGTGCCTCAAAGAAGCCTCGGTGCTG-3 
and  antisense  5-CAGCACCGAGGCTTCTTTGAGGCACGTGAG-3;  for 
N93K, sense 5-GTTCTCGAGGGCATCTGTATCTGCCGCCAG-3 and anti-
sense  5-CTGGCGGCAGATACAGATGCCCTCGAGAAC-3;  for  R702C: 
Rac1/Cdc42 and downstream events. Recent studies suggested 
a possibility for Rho GTPase regulation by MII via the Dbl fam-
ily of GEFs (Wu et al., 2006; Conti and Adelstein, 2008), but its 
mechanism was not determined. In the present study, we showed 
that MII bound a variety of Dbl family proteins with submicro-
molar affinity. Binding occurred through the head domain of 
myosin and the DH–PH region of the GEFs. This interaction in-
creased upon myosin activation and blocked GEF activity toward 
Rac. Accordingly, myosin inactivation in cells triggered release 
of GEFs, leading to activation of Rac and Cdc42 and changes in 
cytoskeletal organization. These data therefore may provide a 
novel molecular mechanism for a variety of observations in which 
inhibition or removal of MII leads to lamellipodia formation, 
changes in cell adhesions, and increased cell motility (Katsumi   
et al., 2002; Sandquist et al., 2006; Even-Ram et al., 2007; Vicente-
Manzanares et al., 2007).
MII showed substantial association with a surprising num-
ber of Dbl family GEFs, perhaps consistent with its interaction 
with the conserved DH–PH module. This result may imply that 
the interaction is mediated by conserved residues in the DH do-
mains. Despite their structural and functional homology, se-
quence homology between different Rac and Cdc42 GEFs is 
often as low as 20% (Schmidt and Hall, 2002). It will therefore 
be interesting to further map the residues responsible for myosin 
binding  and  determine  the  relationship  to  myosin-dependent 
GTPase activation. Furthermore, although our collective data 
suggest a relatively general interaction between MII and GEFs, 
their functional contributions should be assessed with caution. 
For instance, the RhoA-specific GEF-H1 was released from MII 
upon treatment with BBS or antimycin A but RhoA activation 
was not observed. Suppression of Rho by more robust or faster 
activation of Rac/Cdc42 provides one possible explanation, but 
further work is required to fully understand the specificity for 
Rac and Cdc42.
We identified PDGF stimulation as one physiological sys-
tem where this mechanism comes into play. PDGF is well known 
to induce myosin inactivation (Sander et al., 1999; Komatsu and 
Ikebe, 2007). We observed that PDGF triggered transient dissoci-
ation of GEFs from MII after MII inactivation, which correlated 
with a late wave of Rac1 activation. Importantly, phosphomimetic 
constitutively active MLC mutants abrogated PDGF-stimulated 
release of GEFs and activation of Rac. Our collective data there-
fore point to MII inactivation as an upstream event in PDGF- 
induced dissociation of the MII–GEF complex. The resultant 
Rac1 activation may further inactivate MII, thus forming a posi-
tive feedback loop, which contributes to persistence of direc-
tional migration.
Our data show that multiple nonmuscle and muscle iso-
forms of MII bind Rho family GEFs, indicating that it is a con-
served  function.  However,  quantitative  differences  in  affinity 
were noted. It will therefore be interesting to test whether these 
differences in affinities for GEFs contribute to the functional dif-
ferences between myosin isoforms. Thus, the distinct roles of 
MIIA and MIIB in cell migration may depend on different affini-
ties for GEFs, as well as their different cellular locations and dy-
namics of assembly and disassembly (Even-Ram et al., 2007; 
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DH–PH domains (5 µg) in binding buffer (15 mM Tris HCl, pH 7.5, 2.5 mM 
MgCl2, 0.1 mM EGTA, and 0.05% Triton X-100) at 25°C for 30 min. The 
mixture was then pulled down by glutathione agarose beads. To analyze the 
effect of F-actin on the binding between MII and His-tagged DH–PH domain 
(Fig. 4 C), they were incubated in the absence or presence of 0.2 mg/ml 
preformed F-actin in binding buffer at 25°C for 1 h. The MII–DH–PH complex 
was pulled down using Ni
2+ beads. Pull-down assays to test the effect of MII 
on the GEF activity of the DH–PH domain in vitro used His-DH–PH (2 µg) and 
His-Rac1 (2 µg) preloaded with 1 mM GDPS. They were incubated with or 
without skeletal muscle MII for 30 min, and with or without BBS (50 µM). 
These mixtures were then incubated with 100 µM GTPS at 25°C for 30 min 
to allow GTPase activation. Active Rac1 was pulled down with GST-PBD 
(p21 binding domain) and analyzed by immunoblotting for Rac1 (Benard   
et al., 1999). For cell experiments, NIH3T3 cells were treated with 50 µM 
BBS, 100 nM antimycin A, 10 µM cytochalasin D, or 10 µM nocodazole for 
30 min (Fig. 5 B). Active Rac1, Cdc42, or RhoA in the lysates was pulled 
down by GST-PBD or GST-RBD (Rhotekin binding domain; Ren et al., 1999).
Surface plasmon resonance binding assay
Kinetic analysis of the interaction of DH–PH domains and skeletal muscle MII 
used a BIAcore 2000 instrument (Biacore). Sensor NTA chips (GE Health-
care) were loaded with 0.5 mM nickel sulfate in running buffer (10 mM 
Hepes, pH 7.4, 150 mM NaCl, 50 µM EDTA, and 0.005% Surfactant P20) 
and incubated with purified His-tagged DH–PH domains from PIX, Vav1, or 
Tiam1 and the C-terminal half of PIX (C-PIX) as a negative control at a flow 
rate of 10 µl/min until recording a signal of 8,000 response units (RU). 
Various concentrations of skeletal muscle MII were then injected into the flow 
cells at a flow rate of 20 µl/min. Specific binding of MII with DH–PH domain 
was obtained by subtracting nonspecific binding of MII with C-PIX. The equi-
librium dissociation constant (Kd = kd/ka) was derived from the calculated 
dissociation rate constant (kd) and the association rate constant (ka) using   
BIAevaluation software, version 3.0.2 (GE Healthcare). Kinetic data fitted to 
the 1:1 binding model with a drifting baseline.
Statistical analysis
Paired t tests were performed using SPSS version 10.0 for Windows (SPSS) 
and the statistical significance was set at P < 0.05.
Online supplemental material
Fig. S1 shows colocalization of exogenously introduced PIX (myc-PIX) 
and MIIs in Swiss 3T3 fibroblasts. Fig. S2 shows colocalization of endoge-
nous PIX/Trio and MIIs in NIH3T3 fibroblasts. Fig. S3 shows dissociation 
of the MII–GEF complex by treatment with ML-7, Y-27632, or antimycin A. 
Fig. S4 shows BBS-induced dissociation of the MII–PIX complex and alter-
ations in PIX staining in NIH3T3 cells. Fig. S5 shows that expression of   
active MLC mutants (MLC
AA or MLC
EE) inhibits the dissociation of MII–Trio 
complex.  Online  supplemental  material  is  available  at  http://www.jcb 
.org/cgi/content/full/jcb.201003057/DC1.
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HMM (MIIB): sense 5-GAATTGACATGCTTGAAAGAAGCTTCCGTT-3 and 
antisense  5-AACGGAAGCTTCTTTCAAGCATGTCAATTC-3;  for  N97K,   
sense 5-GTCCTGGAAGGGATCTGCATCTGTCGCCAG-3 and antisense 
5-CTGGCGACAGATGCAGATCCCTTCCAGGAC-3;  for  R709C:  MLC
AA: 
sense 5-GTCGACCATGGCGGCCAAAAAGGCAAAGAC-3 and anti-
sense 5-GTCTTGCCTTTTTGGCCGCCATGGTCGAC-3; for MLC
EE: sense 
5-CCTCAGCGTGCAGAAGAGAATGTGTTTGCCATG-3  and  antisense 
5-GGCAAACACATTCTCTTCTGCACGCTGAGG-3.
Cell culture and transfection
NIH3T3, Swiss 3T3, 293T, C2C12, and PC12 cells were cultured in DME   
(Invitrogen) and Jurkat T cells were cultured in RPMI1640 (Invitrogen) supple-
mented with 10% fetal bovine serum and 100 U/ml penicillin/streptomycin 
(Invitrogen) at 37°C in a humidified 5% CO2 incubator. For the ATP depletion 
study, cells were cultured in the depletion medium containing indicated con-
centrations of antimycin A for 30 min (Canfield et al., 1991). For transfections, 
cells in 60-mm-diameter dishes or on fibronectin-coated coverslips were incu-
bated with a mixture of DNA and LipofectAMINE 2000 (Invitrogen) according 
to the manufacturer’s instructions. Cells were used 24–48 h after transfection.
Fluorescence microscopy
Cells were fixed using 3.7% paraformaldehyde in PBS for 15 min, perme-
abilized using 0.2% Triton X-100 in PBS for 2 min, blocked with 2% BSA in 
PBS, and stained with the indicated primary antibodies for at 4°C over-
night, followed by incubation with a secondary Alexa Fluor 488–, 546– or 
594–conjugated antibody. F-actin was visualized with TRITC or Alexa Fluor 
350–conjugated phalloidin. Cells were imaged on a laser confocal micro-
scope (LSM 710; Carl Zeiss, Inc.) with a Plan Apochromat 63x objective 
(Carl Zeiss, Inc.). Alterations in cell adhesion/protrusion were visualized 
under an inverted microscope (IX81-ZDC; Olympus) with a PlanApo N 60x 
objective (Olympus). To quantify adhesions, cells were double labeled with 
PIX and vinculin. Both the total cell perimeter and the portion of the perim-
eter occupied by the focal complexes were measured using MetaMorph 
software version 7.1.7 (MDS Analytical Technologies). The relative ratio of 
focal complex formation was defined as the perimeter occupied by the focal 
complexes divided by total cell perimeter. To quantify lamellipodial protru-
sion after BBS treatment, cells were co-stained for PIX and actin. The rela-
tive ratio of lamellipodia formation was defined as the perimeter occupied 
by the lamellipodia divided by total cell perimeter.
Immunoprecipitation and immunoblotting
Rat brain (E18) and cells were lysed in cold lysis buffer containing 50 mM 
Hepes, pH 7.5, 150 mM NaCl, 1 mM NaF, 10% glycerol, 1% Triton X-100, 
200 µM orthovanadate, and protease inhibitor cocktail. Cell lysates were 
immunoprecipitated  with  indicated  antibodies  for  3  h  at  4°C.  Immuno-
precipitates were collected by adding protein A– or G–Sepharose for 3 h 
at 4°C, and washed five times with lysis buffer. Samples were resolved by 
SDS-PAGE, and transferred to a polyvinylidene difluoride membrane in a 
Tris-glycine methanol buffer (25 mM Tris base, 200 mM glycine, and 20% 
methanol). Membranes were blocked with 3% skimmed milk in phosphate-
buffered saline (PBS) containing 0.1% Tween 20 (PBST) for 30 min, incu-
bated with primary antibodies for 1 h, and washed three times with PBST. 
Membranes were blotted with secondary HRP-conjugated antibodies for   
1 h. After five washes with PBST, signals were detected using enhanced 
chemiluminescence (ECL) reagent (GE Healthcare). In some cases, mem-
branes were stripped and reprobed with different antibodies (Shin et al., 
2004). To quantify MII-bound GEFs, densitometry was performed using 
Quantity One software version 4.6.7 (Bio-Rad Laboratories).
Fractionation for soluble and assembled myosin II
NIH3T3 cells were extracted in situ with cytoskeleton stabilization buffer   
(10 mM Pipes, pH 6.8, 50 mM NaCl, 2.5 mM MgCl2, 1 mM EGTA, 0.3 M 
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